MedTrace Logo

Phase 1 BA Study, Single Center With Healthy Volunteers

NCT00870948 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2010-11-08

No results posted yet for this study

Summary

Single dose in healthy volunteers to assess bioavailability (amount of study drug in the system) between different formulations of ABT-874.

Conditions

  • Healthy

Interventions

DRUG

ABT-874

See Arm Description for details regarding specific Intervention Description that is attributed to each Arm, respectively.

Sponsors & Collaborators

Principal Investigators

  • Joaquin Valdes, MD · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870948 on ClinicalTrials.gov